Hunan Fangsheng Pharm Co Ltd (603998) - Cash Flow Conversion Efficiency

Latest as of September 2025: 0.055x

Based on the latest financial reports, Hunan Fangsheng Pharm Co Ltd (603998) has a cash flow conversion efficiency ratio of 0.055x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥95.63 Million ≈ $13.99 Million USD) by net assets (CN¥1.75 Billion ≈ $256.40 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See net asset quality index of Hunan Fangsheng Pharm Co Ltd to measure how much of total assets are equity-financed.

Hunan Fangsheng Pharm Co Ltd - Cash Flow Conversion Efficiency Trend (2011–2025)

This chart illustrates how Hunan Fangsheng Pharm Co Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. Check 603998 cash flow quality score to evaluate the quality of earnings relative to operating cash generation.

Hunan Fangsheng Pharm Co Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Hunan Fangsheng Pharm Co Ltd ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
IntelliEPI Cayman TWO:4971	0.031x
Haesung DS Co Ltd KO:195870	0.049x
Konka Group Co Ltd SHE:000016	0.068x
Ocean’s King Lighting Science & Technology Co Ltd SHE:002724	-0.003x
Peet Ltd AU:PPC	0.104x
Beijing Career International Co Ltd SHE:300662	0.059x
Brainsway Ltd NASDAQ:BWAY	0.015x
Bright Minds Biosciences Inc NASDAQ:DRUG	-0.031x

Annual Cash Flow Conversion Efficiency for Hunan Fangsheng Pharm Co Ltd (2011–2025)

The table below shows the annual cash flow conversion efficiency of Hunan Fangsheng Pharm Co Ltd from 2011 to 2025. For the full company profile with market capitalisation and key ratios, see 603998 company net worth.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-12-31	CN¥1.80 Billion ≈ $263.81 Million	CN¥384.63 Million ≈ $56.28 Million	0.213x	+89.86%
2024-12-31	CN¥1.73 Billion ≈ $253.87 Million	CN¥194.95 Million ≈ $28.53 Million	0.112x	+103.94%
2023-12-31	CN¥1.59 Billion ≈ $232.48 Million	CN¥87.54 Million ≈ $12.81 Million	0.055x	-72.45%
2022-12-31	CN¥1.51 Billion ≈ $220.66 Million	CN¥301.63 Million ≈ $44.14 Million	0.200x	+40.48%
2021-12-31	CN¥1.30 Billion ≈ $190.76 Million	CN¥185.63 Million ≈ $27.16 Million	0.142x	-23.85%
2020-12-31	CN¥1.27 Billion ≈ $185.22 Million	CN¥236.66 Million ≈ $34.63 Million	0.187x	+38.29%
2019-12-31	CN¥1.20 Billion ≈ $175.95 Million	CN¥162.58 Million ≈ $23.79 Million	0.135x	-14.54%
2018-12-31	CN¥1.11 Billion ≈ $162.84 Million	CN¥176.06 Million ≈ $25.76 Million	0.158x	+925.77%
2017-12-31	CN¥1.04 Billion ≈ $151.83 Million	CN¥16.00 Million ≈ $2.34 Million	0.015x	-87.27%
2016-12-31	CN¥979.69 Million ≈ $143.36 Million	CN¥118.70 Million ≈ $17.37 Million	0.121x	+24.64%
2015-12-31	CN¥931.73 Million ≈ $136.34 Million	CN¥90.57 Million ≈ $13.25 Million	0.097x	-13.08%
2014-12-31	CN¥841.94 Million ≈ $123.20 Million	CN¥94.16 Million ≈ $13.78 Million	0.112x	-64.82%
2013-12-31	CN¥386.85 Million ≈ $56.61 Million	CN¥122.97 Million ≈ $17.99 Million	0.318x	+318.63%
2012-12-31	CN¥318.83 Million ≈ $46.66 Million	CN¥24.21 Million ≈ $3.54 Million	0.076x	-69.88%
2011-12-31	CN¥258.49 Million ≈ $37.83 Million	CN¥65.16 Million ≈ $9.54 Million	0.252x	--

About Hunan Fangsheng Pharm Co Ltd

SHG:603998 China Drug Manufacturers - Specialty & Generic

Market Cap

$604.61 Million

CN¥4.13 Billion CNY

Market Cap Rank

#11260 Global

#3136 in China

Share Price

CN¥9.41

Change (1 day)

-0.42%

52-Week Range

CN¥8.85 - CN¥13.01

All Time High

CN¥18.09